Gut Bacteria May Affect Response To Spasm Treatment

What was studied

This preliminary study looked at gut bacteria in children with infantile epileptic spasms syndrome (IESS), a severe epilepsy syndrome in infancy. The researchers enrolled 18 children with IESS and compared them with two age-matched groups: children with focal epilepsy and healthy children.

The team collected stool samples and used 16S ribosomal DNA sequencing to describe the gut microbiota. In the IESS group, they also compared children whose spasms responded to adrenocorticotropic hormone (ACTH) treatment with those who did not respond, using samples taken before and after ACTH therapy.

What they found

Compared with the focal epilepsy group, children with IESS had lower overall gut microbiota diversity. The mix of gut bacteria also differed across the IESS, focal epilepsy, and healthy groups. In IESS, Proteobacteria and Actinobacteria were more abundant, while Ruminococcaceae was lower than in the focal epilepsy and healthy groups. Compared with the healthy group, IESS also had higher Veillonellaceae abundance and lower Lachnospiraceae and Faecalibacterium abundances. The gut microbiota network structure in IESS also appeared weaker.

Before ACTH treatment, children who did not respond to ACTH had lower levels of actinomycetes and bifidobacteria, weaker network aggregation, and downregulated amino acid metabolism pathways than children who did respond. After ACTH treatment, the IESS group showed enhanced network aggregation, lower Bacillus abundance, downregulated retinol metabolism, and differences in which bacterial groups were enriched. Overall, the authors suggest that gut microbiota profiles may be associated with IESS and may have potential as biomarkers of ACTH treatment response.

Limits of the evidence

This was a small, early study with only 18 children with IESS, so the results may not apply broadly. It can show associations, but it cannot prove that gut bacteria cause IESS or determine whether they directly affect ACTH response.

The sequencing method mainly describes which bacteria are present, not exactly what they are doing. The abstract also notes that the findings require validation in larger independent cohorts and that further multi-omic studies are needed to clarify underlying mechanisms.

For families and caregivers

This study suggests that children with IESS may have different gut bacteria than other children, and that these patterns might be related to how well ACTH works. That is interesting because it could someday help researchers understand the disease better or develop biomarkers to predict treatment response.

For now, this does not mean stool testing, probiotics, or diet changes are proven ways to guide or improve ACTH treatment in IESS. Families can view this as an early research signal, not a change in standard care.

What to watch next

Stronger evidence would come from larger independent studies that test whether gut microbiota patterns can reliably predict ACTH response and help clarify the underlying mechanisms.

Terms in this summary

infantile epileptic spasms syndrome (IESS)

A severe epilepsy syndrome in babies and young infants that causes spasms and can affect development.

gut microbiota

The community of bacteria and other microbes living in the intestines.

ACTH therapy

Treatment with adrenocorticotropic hormone, a medicine used for infantile spasms.

16S ribosomal DNA sequencing

A lab method used to identify and compare bacteria in a sample such as stool.

alpha-diversity

A measure of how many different kinds of microbes are present in one sample and how evenly they are spread.

beta-diversity

A measure of how different the microbial communities are between groups or samples.

biomarker

A measurable sign that may help predict a disease, outcome, or treatment response.

dysbiosis

An imbalance in the gut microbial community.